2022 TriNetX Summit Recording – Addressing Research Challenges with Diversity and Inclusion

Hear about reducing bias, promoting social equity, and producing innovative science informed by a representative population.


Diversity is a moral and scientific issue in clinical research. Hear members of the TriNetX community discuss the importance and efforts undertaken to reduce bias, promote social equity and empowerment, and produce innovative science informed by a representative population of patients that will ultimately receive treatment.


Josh Hartman
Director, Clinical Feasibility and Analytics, TriNetX, LLC

Bill Adams, MD
Professor of Pediatrics, Boston University School of Medicine

Laura Doremus
Global Health Insights Associate Director, D&I, Novartis

Vesna Rysdale
Global Strategic Feasibility, PPD

Janel Titus
Real-World Data Engagement Lead, Takeda